Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predictive Factors of TX vs XELOX in MGC
NCT01963702Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Aug 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in gastric cancer (GC), gastroesophageal adenocarcinoma, sponsored by Fudan University. Status: unknown.
02
Drugs
docetaxel
03
Conditions
gastric cancer (GC)gastroesophageal adenocarcinoma
Beyond the preview
Go deeper on NCT01963702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01963702.